Healthcare News Source

Filters close
12-May-2025 6:05 PM EDT
Diffinvex Reveals How Cancers Rewire Driver Genes to Beat Chemotherapy
Fundació Institut de Recerca Biomèdica (IRB BARCELONA)

● IRB Barcelona researchers have developed a new computational tool that tracks the evolutionary shifts in selection pressure during tumorigenesis and chemotherapy. ● Using more than 8,500 cancer whole-genome sequences, the team identified 11 cancer driver genes linked to chemoresistance to specific anticancer drugs. ● The study has been published in the journal Nature Communications.

Released: 12-May-2025 7:50 PM EDT
Review of Mental Health Referral Data Highlights Patterns—and Gaps—in 0-5 Care
Children's Hospital Los Angeles

Mental health challenges are common in children in the birth-to-5 age range and often co-occur with medical conditions. However, the tools and diagnostic criteria frequently used for older children and adults, like the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), aren’t intended for infants and young children.

access_time Embargo lifts in 2 days
Embargo will expire: 15-May-2025 5:00 PM EDT Released to reporters: 12-May-2025 6:40 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 15-May-2025 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Folic Acid and Pregnancy in Women with Epilepsy
Released: 12-May-2025 6:40 PM EDT
Folic Acid and Pregnancy in Women with Epilepsy
International League Against Epilepsy

Folic acid supplementation is recommended for all women with epilepsy who may become pregnant. However, there is no agreed-upon dose for women with epilepsy taking antiseizure medication, and there may be risks of high-dose (>1 mg/day) folic acid supplementation.

Newswise: Recherche et financement sur l'épilepsie dans les pays à faibles ressources : questions éthiques et étapes vers l'équité
Released: 12-May-2025 6:35 PM EDT
Recherche et financement sur l'épilepsie dans les pays à faibles ressources : questions éthiques et étapes vers l'équité
International League Against Epilepsy

Le terme « écart 10/90 » fait référence au fait que moins de 10 % du financement de la recherche en santé est consacré à la santé dans les pays à faibles ressources, où surviennent 90 % des décès évitables. La recherche sur l'épilepsie est confrontée à des défis similaires à ceux de la recherche sur d'autres pathologies, mais elle présente également des problématiques spécifiques.

access_time Embargo lifts in 2 days
Embargo will expire: 13-May-2025 7:00 AM EDT Released to reporters: 12-May-2025 6:30 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 13-May-2025 7:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: How Neutrophil Calprotectin Unmasks Future Atherosclerotic Heart Disease Risk
Released: 12-May-2025 6:15 PM EDT
How Neutrophil Calprotectin Unmasks Future Atherosclerotic Heart Disease Risk
Michigan Medicine - University of Michigan

This hidden danger can cause ischemic strokes as well as cardiovascular-related deaths

Newswise: UT Southwestern breaks ground on $177M Radiation Oncology campus in Fort Worth
Released: 12-May-2025 6:00 PM EDT
UT Southwestern breaks ground on $177M Radiation Oncology campus in Fort Worth
UT Southwestern Medical Center

Ushering in a new era of cancer care in Fort Worth, UT Southwestern Medical Center broke ground today on a $177 million Radiation Oncology campus that will provide the most advanced therapies for patients of the nation’s 12th-largest city.

Released: 12-May-2025 5:55 PM EDT
UMGCCC Researchers Share New Findings on Link Between Lifetime Alcohol Use and Colorectal Cancer and More at AACR 2025
University of Maryland School of Medicine

University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) researchers, who are on faculty at the University of Maryland School of Medicine, presented findings at the American Association for Cancer Research (AACR) Annual Meeting in Chicago last month.

Released: 12-May-2025 5:50 PM EDT
Researchers Identify Roles of Key Genes in Colon Cancer Development
Michigan Medicine - University of Michigan

Colorectal cancer is the second leading cause of cancer-related death globally. Although some of the molecular changes associated with colorectal cancer are known, how they contribute to cancer development is not yet well defined. In a study published in Journal of Clinical Investigation, researchers used mouse models and studies of colorectal cancer tissues to show that loss of SOX9 gene promotes tumor progression and the pathway it regulates can be a potential target for future treatments.

access_time Embargo lifts in 2 days
Embargo will expire: 19-May-2025 9:20 AM EDT Released to reporters: 12-May-2025 5:25 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 19-May-2025 9:20 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
Embargo will expire: 12-May-2025 5:00 PM EDT Released to reporters: 6-May-2025 8:10 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 12-May-2025 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
Embargo will expire: 12-May-2025 5:00 PM EDT Released to reporters: 6-May-2025 8:25 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 12-May-2025 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
Embargo will expire: 12-May-2025 5:00 PM EDT Released to reporters: 6-May-2025 8:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 12-May-2025 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Olympic Anti-Doping Lab Puts U.S. Meat Supply to the Test
Released: 12-May-2025 11:15 AM EDT
Olympic Anti-Doping Lab Puts U.S. Meat Supply to the Test
University of California, Los Angeles (UCLA), Health Sciences

Scientists at UCLA's Olympic Analytical Laboratory turned their sophisticated analytical capabilities for testing athlete samples for performance-enhancing drugs to research examining the U.S. meat supply as part of a study led by Texas Tech.


  • Previous Page
  • Next Page

Showing results

11 of 1

close
0.10339